These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 38266693)

  • 1. Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease.
    Ullah A; Ullah M; Lim SI
    Curr Probl Cardiol; 2024 Apr; 49(4):102396. PubMed ID: 38266693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recent Developments in Nanomaterials-Based Drug Delivery and Upgrading Treatment of Cardiovascular Diseases.
    Mohamed NA; Marei I; Crovella S; Abou-Saleh H
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multifunctional role of nanoparticles for the diagnosis and therapeutics of cardiovascular diseases.
    Arshad I; Kanwal A; Zafar I; Unar A; Mouada H; Razia IT; Arif S; Ahsan M; Kamal MA; Rashid S; Khan KA; Sharma R
    Environ Res; 2024 Feb; 242():117795. PubMed ID: 38043894
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano revolution in cardiovascular health: Nanoparticles (NPs) as tiny titans for diagnosis and therapeutics.
    Abid J; Khalil FMA; Saeed S; Khan SU; Iqbal I; Khan SU; Anthony S; Shahzad R; Koerniati S; Naz F
    Curr Probl Cardiol; 2024 May; 49(5):102466. PubMed ID: 38369205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances in nanotechnological approaches for the detection of early markers associated with severe cardiac ailments.
    Wang J; Zhang H; Wan W; Yang H; Zhao J
    Nanomedicine (Lond); 2024 Jul; 19(16):1487-1506. PubMed ID: 39121377
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Theranostic Applications of Nanomaterials in the Field of Cardiovascular Diseases.
    Sahoo RK; Singh H; Thakur K; Gupta U; Goyal AK
    Curr Pharm Des; 2022; 28(2):91-103. PubMed ID: 34218771
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Advances in nanobased platforms for cardiovascular diseases: Early diagnosis, imaging, treatment, and tissue engineering.
    Shariati L; Esmaeili Y; Rahimmanesh I; Babolmorad S; Ziaei G; Hasan A; Boshtam M; Makvandi P
    Environ Res; 2023 Dec; 238(Pt 1):116933. PubMed ID: 37652218
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nanoscale Technologies in Highly Sensitive Diagnosis of Cardiovascular Diseases.
    Shi C; Xie H; Ma Y; Yang Z; Zhang J
    Front Bioeng Biotechnol; 2020; 8():531. PubMed ID: 32582663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent advances on nanoparticle-based therapies for cardiovascular diseases.
    Soumya RS; Raghu KG
    J Cardiol; 2023 Jan; 81(1):10-18. PubMed ID: 35210166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoparticle: A Promising Player in Nanomedicine and its Theranostic Applications for the Treatment of Cardiovascular Diseases.
    Saeed S; Ud Din SR; Khan SU; Gul R; Kiani FA; Wahab A; Zhong M
    Curr Probl Cardiol; 2023 May; 48(5):101599. PubMed ID: 36681209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The recent applications of nanotechnology in the diagnosis and treatment of common cardiovascular diseases.
    Li F; Shao H; Zhou G; Wang B; Xu Y; Liang W; Chen L
    Vascul Pharmacol; 2023 Oct; 152():107200. PubMed ID: 37500029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Emergence of Nanotechnology in the Prognosis and Treatment of Myocardial Infarctions.
    Sharma I; Bhardwaj S; Karwasra R; Kaushik D; Sharma S
    Recent Pat Nanotechnol; 2023 Oct; ():. PubMed ID: 37904554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel cutting edge nano-strategies to address old long-standing complications in cardiovascular diseases. A comprehensive review.
    Tesoro L; Hernandez I; Saura M; Badimón L; Zaragoza C
    Eur J Clin Invest; 2024 Jul; 54(7):e14208. PubMed ID: 38622800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergence of nanotechnology and cardiovascular medicine : progress and emerging prospects.
    Iverson N; Plourde N; Chnari E; Nackman GB; Moghe PV
    BioDrugs; 2008; 22(1):1-10. PubMed ID: 18215086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic insights into heart health: Exploring the genetic basis of cardiovascular disease.
    Safdar M; Ullah M; Wahab A; Hamayun S; Ur Rehman M; Khan MA; Khan SU; Ullah A; Din FU; Awan UA; Naeem M
    Curr Probl Cardiol; 2024 Jan; 49(1 Pt C):102182. PubMed ID: 37913933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metal-Based Nanoparticles for Cardiovascular Diseases.
    Scafa Udriște A; Burdușel AC; Niculescu AG; Rădulescu M; Grumezescu AM
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38256075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.
    Pala R; Anju VT; Dyavaiah M; Busi S; Nauli SM
    Int J Nanomedicine; 2020; 15():3741-3769. PubMed ID: 32547026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting Oxidative Stress Using Nanoparticles as a Theranostic Strategy for Cardiovascular Diseases.
    Kim KS; Song CG; Kang PM
    Antioxid Redox Signal; 2019 Feb; 30(5):733-746. PubMed ID: 29228781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetology and Nanotechnology: A Compelling Combination.
    Karwasra R; Sharma S; Sharma I; Shahid N; Umar T
    Recent Pat Nanotechnol; 2023 Nov; ():. PubMed ID: 37937555
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanotechnology and stem cell therapy for cardiovascular diseases: potential applications.
    La Francesca S
    Methodist Debakey Cardiovasc J; 2012 Jan; 8(1):28-35. PubMed ID: 22891108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.